A randomized, double‐blind, single‐dose study to assess bioequivalence of MB02 biosimilar after manufacturing iteration and reference bevacizumab

por Schwabe, C., Cole, A., Espigares‐Correa, A., Beydon, M. E., Florez‐Igual, A., Queiruga‐Parada, J.
Publicado 2023